Nurix Therapeutics Inc
(NRIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 05-2023 | 02-2023 | 11-2022 | 09-2022 | 08-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -65,010 | -40,733 | -180,360 | N/A | -133,643 |
| Depreciation Amortization | 4,705 | 2,362 | 11,234 | N/A | 8,847 |
| Accounts receivable | N/A | N/A | 6,000 | N/A | 6,000 |
| Accounts payable and accrued liabilities | -1,839 | 400 | 85 | N/A | 984 |
| Other Working Capital | -23,916 | -18,618 | -19,022 | N/A | -17,100 |
| Other Operating Activity | 19,139 | 8,137 | 22,256 | 0 | 13,060 |
| Operating Cash Flow | $-66,921 | $-48,452 | $-159,807 | $N/A | $-121,852 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,357 | -2,277 | -12,244 | N/A | -9,679 |
| Purchase Of Investment | -83,353 | -22,642 | -239,366 | N/A | -212,455 |
| Sale Of Investment | 146,609 | 40,987 | 278,808 | N/A | 194,324 |
| Investing Cash Flow | $59,899 | $16,068 | $27,198 | $N/A | $-27,810 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,506 | 1,481 | 22,433 | N/A | 22,385 |
| Other Financing Activity | 0 | 0 | 94,759 | 0 | 94,942 |
| Financing Cash Flow | $1,506 | $1,481 | $117,192 | $N/A | $117,327 |
| Beginning Cash Position | 65,375 | 65,375 | 80,792 | N/A | 80,792 |
| End Cash Position | 59,859 | 34,472 | 65,375 | N/A | 48,457 |
| Net Cash Flow | $-5,516 | $-30,903 | $-15,417 | $N/A | $-32,335 |
| Free Cash Flow | |||||
| Operating Cash Flow | -66,921 | -48,452 | -159,807 | N/A | -121,852 |
| Capital Expenditure | -3,357 | -2,277 | -12,244 | N/A | -9,679 |
| Free Cash Flow | -70,278 | -50,729 | -172,051 | 0 | -131,531 |